These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30220930)

  • 1. SABCS 2017 pathology: from bench to bedside.
    Bago-Horvath Z
    Memo; 2018; 11(3):217-219. PubMed ID: 30220930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highlights from the 38th SABCS annual meeting, 8th - 12th December 2015, San Antonio, USA.
    Cairns L; Curigliano G
    Ecancermedicalscience; 2016; 10():618. PubMed ID: 26913069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Highlights from the 40
    Özkurt E
    Eur J Breast Health; 2018 Apr; 14(2):74-79. PubMed ID: 29774314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the treatment of breast cancer: highlights from the 2010 San Antonio Breast Cancer Symposium.
    Perez E; Burstein HJ; Hudis C
    Clin Adv Hematol Oncol; 2011 May; 9(5 Suppl 11):1-16. PubMed ID: 21738119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational and clinical research highlights from the 38th San Antonio Breast Cancer Symposium.
    Fontanella C; Puglisi F
    Future Oncol; 2016; 12(8):1005-8. PubMed ID: 26856441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report from the 37th san antonio breast cancer symposium, 9-13th december 2014, Texas, USA.
    Ahmed M; Esposito E
    Ecancermedicalscience; 2015; 9():508. PubMed ID: 25729421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highlights of the San Antonio Breast Cancer Symposium 2015: part 1.
    Benson JR; Jatoi I
    Future Oncol; 2016 Apr; 12(7):893-6. PubMed ID: 26880387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2.
    Benson JR; Jatoi I
    Future Oncol; 2017 Jul; 13(16):1365-1369. PubMed ID: 28685613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highlights of the San Antonio Breast Cancer Symposium 2015: part 2.
    Benson JR; Jatoi I
    Future Oncol; 2016 Apr; 12(7):897-900. PubMed ID: 26880386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
    Gnant M; Mlineritsch B; Stoeger H; Luschin-Ebengreuth G; Heck D; Menzel C; Jakesz R; Seifert M; Hubalek M; Pristauz G; Bauernhofer T; Eidtmann H; Eiermann W; Steger G; Kwasny W; Dubsky P; Hochreiner G; Forsthuber EP; Fesl C; Greil R;
    Lancet Oncol; 2011 Jul; 12(7):631-41. PubMed ID: 21641868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the medical management of breast cancer: highlights from the 29th San Antonio Breast Cancer Conference San Antonio, TX, USA, 14-17 December 2007.
    Montemurro F; Redana S; Valabrega G; Aglietta M
    Expert Opin Pharmacother; 2007 Jun; 8(8):1179-88. PubMed ID: 17516881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone.
    Sestak I; Martín M; Dubsky P; Kronenwett R; Rojo F; Cuzick J; Filipits M; Ruiz A; Gradishar W; Soliman H; Schwartzberg L; Buus R; Hlauschek D; Rodríguez-Lescure A; Gnant M
    Breast Cancer Res Treat; 2019 Jul; 176(2):377-386. PubMed ID: 31041683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to the diagnosis and treatment of breast cancer.
    Jatoi I; Benson JR
    Future Oncol; 2014 Mar; 10(4):515-8. PubMed ID: 24754581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 2).
    Benson JR; Jatoi I
    Future Oncol; 2018 Aug; 14(19):1893-1896. PubMed ID: 30019940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 1).
    Benson JR; Jatoi I
    Future Oncol; 2018 Aug; 14(19):1889-1892. PubMed ID: 30019918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
    Gnant M; Mlineritsch B; Luschin-Ebengreuth G; Kainberger F; Kässmann H; Piswanger-Sölkner JC; Seifert M; Ploner F; Menzel C; Dubsky P; Fitzal F; Bjelic-Radisic V; Steger G; Greil R; Marth C; Kubista E; Samonigg H; Wohlmuth P; Mittlböck M; Jakesz R;
    Lancet Oncol; 2008 Sep; 9(9):840-9. PubMed ID: 18718815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highlights of the San Antonio Breast Cancer Symposium 2016.
    Benson JR; Jatoi I
    Future Oncol; 2017 Jun; 13(15):1291-1295. PubMed ID: 28650276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of bisphosphonates in postmenopausal women with breast cancer.
    Gnant M
    Cancer Treat Rev; 2014 Apr; 40(3):476-84. PubMed ID: 23906846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.